| BH2 | Name: | (3R)-3-hydroxy-L-aspartic acid | Formula: | C4 H7 N O5 | SMILES: | O=C(O)C(O)C(C(=O)O)N | InChi: | InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2+/m0/s1 | Definition date: | 2011-01-07 | Last modified: | 2024-09-27 | Identifier: | (3R)-3-hydroxy-L-aspartic acid |
|
| BH6 | Name: | {[(2-chlorobenzoyl)amino]methyl}boronic acid | Formula: | C8 H9 B Cl N O3 | SMILES: | O=C(c1ccccc1Cl)NCB(O)O | InChi: | InChI=1S/C8H9BClNO3/c10-7-4-2-1-3-6(7)8(12)11-5-9(13)14/h1-4,13-14H,5H2,(H,11,12) | Definition date: | 2011-01-13 | Last modified: | 2024-09-27 | Identifier: | {[(2-chlorobenzoyl)amino]methyl}boronic acid |
|
| BHD | Name: | (3S)-3-hydroxy-L-aspartic acid | Formula: | C4 H7 N O5 | SMILES: | O=C(O)C(O)C(C(=O)O)N | InChi: | InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2-/m0/s1 | Synonyms: | BETA-HYDROXYASPARTIC ACID | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-hydroxy-L-aspartic acid |
|
| BIF | Name: | (R)-2-AMINO-3-(4-PHENYLCYCLOHEXYL)PROPANOIC ACID | Formula: | C15 H15 N O2 | SMILES: | O=C(O)C(N)Cc1ccc(cc1)c2ccccc2 | InChi: | InChI=1S/C15H15NO2/c16-14(15(17)18)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9,14H,10,16H2,(H,17,18)/t14-/m0/s1 | Synonyms: | BIPHENYLALANINE | Definition date: | 2005-03-29 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-3-biphenyl-4-ylpropanoic acid (non-preferred name) |
|
| BIP | Name: | 2-BENZYL-3-IODOPROPANOIC ACID | Formula: | C10 H11 I O2 | SMILES: | O=C(O)C(CI)Cc1ccccc1 | InChi: | InChI=1S/C10H11IO2/c11-7-9(10(12)13)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,12,13)/t9-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-benzyl-3-iodopropanoic acid |
|
| BIX | Name: | (2S)-2-{[(S)-[(3S)-3-amino-3-carboxypropyl](hydroxy)phosphoryl]methyl}pentanedioic acid | Formula: | C10 H18 N O8 P | SMILES: | O=C(O)CCC(C(=O)O)CP(=O)(O)CCC(C(=O)O)N | InChi: | InChI=1S/C10H18NO8P/c11-7(10(16)17)3-4-20(18,19)5-6(9(14)15)1-2-8(12)13/h6-7H,1-5,11H2,(H,12,13)(H,14,15)(H,16,17)(H,18,19)/t6-,7+/m1/s1 | Definition date: | 2007-11-30 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-{[(S)-[(3S)-3-amino-3-carboxypropyl](hydroxy)phosphoryl]methyl}pentanedioic acid |
|
| BIY | Name: | (3S)-2,2-dimethyl-3,4-dihydro-2H-1,4-thiazine-3,6-dicarboxylic acid | Formula: | C8 H11 N O4 S | SMILES: | O=C(O)C=1SC(C)(C)C(C(=O)O)NC=1 | InChi: | InChI=1S/C8H11NO4S/c1-8(2)5(7(12)13)9-3-4(14-8)6(10)11/h3,5,9H,1-2H3,(H,10,11)(H,12,13)/t5-/m0/s1 | Definition date: | 2009-06-04 | Last modified: | 2024-09-27 | Identifier: | (3S)-2,2-dimethyl-3,4-dihydro-2H-1,4-thiazine-3,6-dicarboxylic acid |
|
| BJH | Name: | 1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID | Formula: | C11 H14 B N O6 | SMILES: | O=C(O)c1cccc(c1O)CC(B(O)O)NC(=O)C | InChi: | InChI=1S/C11H14BNO6/c1-6(14)13-9(12(18)19)5-7-3-2-4-8(10(7)15)11(16)17/h2-4,9,15,18-19H,5H2,1H3,(H,13,14)(H,16,17)/t9-/m0/s1 | Definition date: | 2000-04-20 | Last modified: | 2024-09-27 | Identifier: | 3-[(2R)-2-(acetylamino)-2-(dihydroxyboranyl)ethyl]-2-hydroxybenzoic acid |
|
| BJI | Name: | 1(R)-1-ACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID | Formula: | C11 H14 B N O5 | SMILES: | O=C(O)c1cc(ccc1)CC(NC(=O)C)B(O)O | InChi: | InChI=1S/C11H14BNO5/c1-7(14)13-10(12(17)18)6-8-3-2-4-9(5-8)11(15)16/h2-5,10,17-18H,6H2,1H3,(H,13,14)(H,15,16)/t10-/m0/s1 | Definition date: | 2000-04-17 | Last modified: | 2024-09-27 | Identifier: | 3-[(2R)-2-(acetylamino)-2-(dihydroxyboranyl)ethyl]benzoic acid |
|
| BJL | Name: | N-[(3R)-4-ethoxy-3-hydroxy-4-oxobutanoyl]-L-tyrosine | Formula: | C15 H19 N O7 | SMILES: | C(c1ccc(cc1)O)C(C(O)=O)NC(CC(O)C(OCC)=O)=O | InChi: | InChI=1S/C15H19NO7/c1-2-23-15(22)12(18)8-13(19)16-11(14(20)21)7-9-3-5-10(17)6-4-9/h3-6,11-12,17-18H,2,7-8H2,1H3,(H,16,19)(H,20,21)/t11-,12+/m0/s1 | Definition date: | 2019-02-07 | Last modified: | 2024-09-27 | Release date: | 2019-05-01 | Identifier: | N-[(3R)-4-ethoxy-3-hydroxy-4-oxobutanoyl]-L-tyrosine |
|
| BJM | Name: | (2~{S})-2-azanyl-1-[(1~{S},3~{S},5~{S})-3-(iminomethyl)-2-azabicyclo[3.1.0]hexan-2-yl]-2-[(5~{R},7~{S})-3-oxidanyl-1-ad
amantyl]ethanone | Formula: | C18 H27 N3 O2 | SMILES: | N[CH](C(=O)N1[CH](C[CH]2C[CH]12)C=N)C34C[CH]5C[CH](CC(O)(C5)C3)C4 | InChi: | InChI=1S/C18H27N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h8,10-15,19,23H,1-7,9,20H2/t10-,11+,12-,13+,14+,15-,17+,18-/m1/s1 | Synonyms: | Saxagliptin, bound form | Definition date: | 2007-12-13 | Last modified: | 2024-09-27 | Identifier: | (2~{S})-2-azanyl-1-[(1~{S},3~{S},5~{S})-3-(iminomethyl)-2-azabicyclo[3.1.0]hexan-2-yl]-2-[(5~{R},7~{S})-3-oxidanyl-1-adamantyl]ethanone |
|
| BJO | Name: | (4Z)-4-amino-4-{1-(carboxymethyl)-5-oxo-4-[(4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-1,5-dihydro-2H-imidazol-2-ylidene}butanoic acid | Formula: | C16 H15 N3 O6 | SMILES: | O=C(CCC(=C2/N=C(C=C1/C=CC(C=C1)=O)C(=O)N2CC(=O)O)N)O | InChi: | InChI=1S/C16H15N3O6/c17-11(5-6-13(21)22)15-18-12(16(25)19(15)8-14(23)24)7-9-1-3-10(20)4-2-9/h1-4,7H,5-6,8,17H2,(H,21,22)(H,23,24)/b15-11- | Synonyms: | CHROMOPHORE (GLU-TYR-GLY) | Definition date: | 2019-02-07 | Last modified: | 2024-09-27 | Release date: | 2019-03-20 | Identifier: | (4Z)-4-amino-4-{1-(carboxymethyl)-5-oxo-4-[(4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-1,5-dihydro-2H-imidazol-2-ylidene}butanoic acid |
|
| BJP | Name: | (1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID | Formula: | C17 H18 B N O5 | SMILES: | O=C(O)c1cc(ccc1)CC(NC(=O)Cc2ccccc2)B(O)O | InChi: | InChI=1S/C17H18BNO5/c20-16(11-12-5-2-1-3-6-12)19-15(18(23)24)10-13-7-4-8-14(9-13)17(21)22/h1-9,15,23-24H,10-11H2,(H,19,20)(H,21,22)/t15-/m0/s1 | Definition date: | 2000-04-19 | Last modified: | 2024-09-27 | Identifier: | 3-{(2R)-2-(dihydroxyboranyl)-2-[(phenylacetyl)amino]ethyl}benzoic acid |
|
| BJU | Name: | N-tetradecanoylglycine | Formula: | C16 H31 N O3 | SMILES: | C(CCCC(=O)NCC(O)=O)CCCCCCCCC | InChi: | InChI=1S/C16H31NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-15(18)17-14-16(19)20/h2-14H2,1H3,(H,17,18)(H,19,20) | Definition date: | 2019-02-07 | Last modified: | 2024-09-27 | Release date: | 2024-03-27 | Identifier: | N-tetradecanoylglycine |
|
| BKM | Name: | (2Z)-2-[(1R)-3-{[(2R,3S,4R,7S,8S,11S,13R,16E)-17-ethyl-4,8-dihydroxy-3,7,11,13-tetramethyl-6,15-dioxononadeca-16,18-dien-2-yl]oxy}-1-hydroxy-3-oxopropyl]-3-methylbut-2-enedioic acid | Formula: | C33 H52 O11 | SMILES: | C=[C@H]C(=[C@H]C(CC(CC(C)CCC(C(C)C(CC(O)C(C)C(C)OC(=O)CC(/C(C(O)=O)=C(/C(=O)O)C)O)=O)O)C)=O)CC | InChi: | InChI=1S/C33H52O11/c1-9-24(10-2)15-25(34)14-19(4)13-18(3)11-12-26(35)21(6)28(37)16-27(36)20(5)23(8)44-30(39)17-29(38)31(33(42)43)22(7)32(40)41/h9,15,18-21,23,26-27,29,35-36,38H,1,10-14,16-17H2,2-8H3,(H,40,41)(H,42,43)/b24-15-,31-22-/t18-,19+,20+,21-,23+,26-,27+,29+/m0/s1 | Synonyms: | Tautomycetin diacid form | Definition date: | 2017-08-10 | Last modified: | 2024-09-27 | Release date: | 2017-11-29 | Identifier: | (2Z)-2-[(1R)-3-{[(2R,3S,4R,7S,8S,11S,13R,16E)-17-ethyl-4,8-dihydroxy-3,7,11,13-tetramethyl-6,15-dioxononadeca-16,18-dien-2-yl]oxy}-1-hydroxy-3-oxopropyl]-3-methylbut-2-enedioic acid |
|
| BL2 | Name: | N-(tert-butoxycarbonyl)-L-leucine | Formula: | C11 H21 N O4 | SMILES: | O=C(OC(C)(C)C)NC(C(=O)O)CC(C)C | InChi: | InChI=1S/C11H21NO4/c1-7(2)6-8(9(13)14)12-10(15)16-11(3,4)5/h7-8H,6H2,1-5H3,(H,12,15)(H,13,14)/t8-/m0/s1 | Definition date: | 2012-05-31 | Last modified: | 2024-09-27 | Release date: | 2013-05-22 | Identifier: | N-(tert-butoxycarbonyl)-L-leucine |
|
| BL8 | Name: | 3-[2-[(Z)-[5-[(Z)-[(3R,4R)-3-ethenyl-4-methyl-5-oxidanylidene-pyrrolidin-2-ylidene]methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-pyrrol-2-ylidene]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid | Formula: | C33 H36 N4 O6 | SMILES: | C[CH]1[CH](C=C)C(NC1=O)=CC2=NC(=Cc3[nH]c(C=C4NC(=O)C(=C4C)C=C)c(C)c3CCC(O)=O)C(=C2C)CCC(O)=O | InChi: | InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,19-20,34H,1-2,9-12H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-,29-15-/t19-,20-/m1/s1 | Definition date: | 2015-03-16 | Last modified: | 2024-09-27 | Release date: | 2015-12-09 | Identifier: | 3-[2-[(Z)-[5-[(Z)-[(3R,4R)-3-ethenyl-4-methyl-5-oxidanylidene-pyrrolidin-2-ylidene]methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-pyrrol-2-ylidene]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid |
|
| BLR | Name: | 3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-2-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid | Formula: | C33 H36 N4 O6 | SMILES: | CC1=C(C=C)C(NC1=O)=Cc2[nH]c(Cc3[nH]c(C=C4NC(=O)C(=C4C)C=C)c(C)c3CCC(O)=O)c(CCC(O)=O)c2C | InChi: | InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14- | Synonyms: | Bilirubin IX alpha | Definition date: | 2015-01-26 | Last modified: | 2024-09-27 | Release date: | 2015-02-04 | Identifier: | 3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-2-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid |
|
| BMA | Name: | beta-D-mannopyranose | Formula: | C6 H12 O6 | SMILES: | OC1C(O)C(OC(O)C1O)CO | InChi: | InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6-/m1/s1 | Synonyms: | beta-D-mannose | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | beta-D-mannopyranose |
|
| BMG | Name: | (4R,5S)-3-(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-ylsulfanyl)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-4-meth
yl-4,5-dihydro-1H-pyrrole-2-carboxylate | Formula: | C15 H20 N4 O4 S | SMILES: | O=CC(C(O)C)C3NC(C([O-])=O)=C(SC2C[n+]1cncn1C2)C3C | InChi: | InChI=1S/C15H20N4O4S/c1-8-12(11(5-20)9(2)21)17-13(15(22)23)14(8)24-10-3-18-6-16-7-19(18)4-10/h5-12,17,21H,3-4H2,1-2H3/t8-,9-,11-,12-/m1/s1 | Synonyms: | (4R,5S)-3-(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-ylthio)-5-((2S,3R)-3-hydroxy-1-oxobutan-2-yl)-4-
methyl-4,5-dihydro-1H-pyrrole-2-carboxylate | Definition date: | 2007-11-05 | Last modified: | 2024-09-27 | Identifier: | (4R,5S)-3-(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-ylsulfanyl)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylate |
|
| 6J9 | Name: | 4-(piperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine | Formula: | C10 H13 N5 | SMILES: | c2(c1c(ncc1)ncn2)N3CCNCC3 | InChi: | InChI=1S/C10H13N5/c1-2-12-9-8(1)10(14-7-13-9)15-5-3-11-4-6-15/h1-2,7,11H,3-6H2,(H,12,13,14) | Definition date: | 2016-04-14 | Last modified: | 2024-09-27 | Release date: | 2016-07-20 | Identifier: | 4-(piperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine |
|
| 6KG | Name: | Nalpha-[(2S)-2-{[(2S)-2-azido-3-phenylpropanoyl]amino}-4-cyclohexylbutanoyl]-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-phenylalaninamide | Formula: | C37 H54 N6 O5 | SMILES: | c1ccc(cc1)CC(C(NC(C(=O)NC(Cc2ccccc2)C(NC(CC(C)C)C(O)C(C)CO)=O)CCC3CCCCC3)=O)N=[N+]=[N-] | InChi: | InChI=1S/C37H54N6O5/c1-25(2)21-31(34(45)26(3)24-44)40-36(47)32(22-28-15-9-5-10-16-28)41-35(46)30(20-19-27-13-7-4-8-14-27)39-37(48)33(42-43-38)23-29-17-11-6-12-18-29/h5-6,9-12,15-18,25-27,30-34,44-45H,4,7-8,13-14,19-24H2,1-3H3,(H,39,48)(H,40,47)(H,41,46)/t26-,30+,31+,32+,33+,34+/m1/s1 | Definition date: | 2016-04-22 | Last modified: | 2024-09-27 | Release date: | 2016-08-03 | Identifier: | Nalpha-[(2S)-2-{[(2S)-2-azido-3-phenylpropanoyl]amino}-4-cyclohexylbutanoyl]-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-phenylalaninamide |
|
| 6KM | Name: | S-propanoyl-L-cysteine | Formula: | C6 H11 N O3 S | SMILES: | NC(CSC(CC)=O)C(=O)O | InChi: | InChI=1S/C6H11NO3S/c1-2-5(8)11-3-4(7)6(9)10/h4H,2-3,7H2,1H3,(H,9,10)/t4-/m0/s1 | Definition date: | 2016-04-22 | Last modified: | 2024-09-27 | Release date: | 2017-03-01 | Identifier: | S-propanoyl-L-cysteine |
|
| 6L3 | Name: | methyl 2,4,6-trimethylbenzoate | Formula: | C11 H14 O2 | SMILES: | Cc1c(c(cc(c1)C)C)C(=O)OC | InChi: | InChI=1S/C11H14O2/c1-7-5-8(2)10(9(3)6-7)11(12)13-4/h5-6H,1-4H3 | Definition date: | 2016-04-26 | Last modified: | 2024-09-27 | Release date: | 2016-05-04 | Identifier: | methyl 2,4,6-trimethylbenzoate |
|
| 6L4 | Name: | ~{N}-[2-[5-chloranyl-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide | Formula: | C17 H15 Cl N6 O2 | SMILES: | Cn1cc(Nc2ncc(Cl)c(Oc3ccccc3NC(=O)C=C)n2)cn1 | InChi: | InChI=1S/C17H15ClN6O2/c1-3-15(25)22-13-6-4-5-7-14(13)26-16-12(18)9-19-17(23-16)21-11-8-20-24(2)10-11/h3-10H,1H2,2H3,(H,22,25)(H,19,21,23) | Synonyms: | N-(2-((5-chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)oxy)phenyl)acrylamide | Definition date: | 2016-04-26 | Last modified: | 2024-09-27 | Release date: | 2017-02-15 | Identifier: | ~{N}-[2-[5-chloranyl-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide |
|